Jaebok Choi

Assistant Professor

Washington University in Saint Louis School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jaebok Choi is an Assistant Professor at Washington University School of Medicine in St. Louis, USA. His research areas focus on graft-versus-host disease, hematopoietic cell transplantation, and hematologic malignancies. He has authored recent articles that explore various therapeutic strategies, including JAK inhibitors and the role of specific proteins in immune responses and cell maturation.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Xiang-An Li

University of Kentucky College of Medicine

UNITED STATES

University of Kentucky

UNITED STATES

View details

Samuel Achilefu

Chair/Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Michael Rettig

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jaebok Choi

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation

Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model

HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

The adrenal stress response is an essential host response against therapy-induced lethal immune activation

S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice

S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models

Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation

Restoring NK cell functions in AML relapse

Editorial: Interferons and GvHD

Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR

Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation

Selective targeting of α4β1 integrin attenuates murine graft versus host disease

Collaborators (9)

Xiang-An Li

Daniel Weisdorf

Feng Gao

Chieko Mineo

Mark Fiala

Eric Huselton

Qian Wang

Samuel Achilefu

Michael Rettig

Make your next move.